If you are a member of local or national media,
Cure SMA is pleased to provide resources and contacts for stories related to SMA.

Media Contact

Contact Michelle Pantoja, Marketing Manager at [email protected] or 847.264.1196  for:

  • More information on recent news articles.
  • SMA facts, figures, and resources.
  • Interviews with SMA experts or people and families impacted by SMA.
  • Questions about logo usage and permissions.

Cure SMA Boilerplates

About SMA

SMA is a progressive neurodegenerative disease that robs an individual of their ability to walk, eat, and breathe. SMA is the leading genetic cause of death for infants. Symptoms can surface within the first 6 months of life (Type 1, the most severe and common), during the toddler years (Types 2 and 3), or in adulthood (Type 4, the least common form). SMA affects 1 in 11,000 births in the United States each year, and approximately 1 in 50 Americans is a genetic carrier. There are now multiple highly effective treatments for SMA approved by the U.S. Food and Drug Administration (FDA) that make it possible for babies diagnosed with SMA to achieve developmental milestones and individuals with SMA to live full and productive lives.

About Cure SMA

Cure SMA is dedicated to the treatment and cure of SMA. Since 1984, Cure SMA has grown to be the largest network of individuals, families, clinicians, and research scientists working together to advance SMA research, support the full SMA community, and educate public and professional communities about SMA. The organization has directed and invested in comprehensive research that has shaped the scientific community’s understanding of SMA, led to breakthroughs in treatment and care, and provides individuals and families the support they need today. For more information, visit https://www.curesma.org/.